| Anti-TB drug |
Number of isolates tested |
Susceptible n(%) |
Intermediate Resistant |
Resistant |
| STR |
121 |
71(58.68%) |
12 (9.92%) |
38 (31.40%) |
| INH |
121 |
102 (84.30%) |
1(0.82%) |
18 (14.88%) |
| RIF |
121 |
113(93.39%) |
0 |
8 (6.61%) |
| EMB |
121 |
117(96.69%) |
0 |
4 (3.31%) |
| STR/INH |
121 |
|
|
10 (8.26%) |
| STR/RIF |
121 |
|
|
2 (1.65%) |
| INH/EMB |
121 |
|
|
1(0.82%) |
| MDR |
121 |
|
|
3 (2.48%) |
n = number |
